Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tempus AI
TEM
5
Roblox
RBLX
暂无数据
Trinity Biotech 报告了在下一代 CGM+ 平台上的重大技术突破。
Trinity Biotech预计2025年第四季度收入下降,因加速推进制造转型与增长计划
Trinity Biotech 预计第四季度收入范围约为 $1,150万 - $1,250万
Trinity Biotech plc(纳斯达克:TRIB)是一家专注于人类诊断和糖尿病管理解决方案(包括可穿戴生物传感器)的处于商业化阶段的生物技术公司,今天宣布了一项更新。
Trinity Biotech Anticipates Some HIV Rev Will Shift From 1Q Into 2Q and Also From 2Q Into 3Q
Trinity Biotech Cites Residual Impact of Disruption to Global Health Market for HIV Testing in 2025 Due to Changes Affecting Intl Aid Funding Structures >TRIB
Trinity Biotech Sees 4Q Rev $11.5M-$12.5M >TRIB